# [愿景论文] PRObot：使用聊天机器人和生成式人工智能增强糖尿病视网膜病变的患者报告结局指标

发布时间：2024年11月05日

`LLM应用` `糖尿病`

> [Vision Paper] PRObot: Enhancing Patient-Reported Outcome Measures for Diabetic Retinopathy using Chatbots and Generative AI

# 摘要

> 我们在糖尿病视网膜病变患者报告的结果测量（PROMs）的背景下，展示了第一个基于大型语言模型（LLM）的聊天机器人应用的大纲。通过利用当前 LLM 的能力，我们使患者能够通过交互式应用程序提供关于他们生活质量和治疗进展的反馈。所提出的框架与当前的方法相比具有显著的优势，当前的方法仅包括定性收集调查数据或具有有限答案选项的静态调查。使用 PROBot LLM-PROM 应用程序，将向患者询问有关其个人挑战的定制问题，并能够就其治疗进展提供更详细的反馈。基于此输入，我们将使用机器学习来推断常规的 PROM 分数，临床医生可以使用这些分数来评估治疗状态。该应用程序的目标是提高对医疗保健系统和治疗的依从性，从而最终减少后续视力损害的病例。该方法需要通过调查和临床研究进一步验证。

> We present an outline of the first large language model (LLM) based chatbot application in the context of patient-reported outcome measures (PROMs) for diabetic retinopathy. By utilizing the capabilities of current LLMs, we enable patients to provide feedback about their quality of life and treatment progress via an interactive application. The proposed framework offers significant advantages over the current approach, which encompasses only qualitative collection of survey data or a static survey with limited answer options. Using the PROBot LLM-PROM application, patients will be asked tailored questions about their individual challenges, and can give more detailed feedback on the progress of their treatment. Based on this input, we will use machine learning to infer conventional PROM scores, which can be used by clinicians to evaluate the treatment status. The goal of the application is to improve adherence to the healthcare system and treatments, and thus ultimately reduce cases of subsequent vision impairment. The approach needs to be further validated using a survey and a clinical study.

[Arxiv](https://arxiv.org/abs/2411.02973)